Date | Total Assets | Current Liabilities | Total Non-Current Liabilities | Shareholders' Equity |
---|
CEO | Mr. Rahul Franklin Guha |
IPO Date | May 10, 2016 |
Location | India |
Headquarters | D/37-3, TTC Industrial Area |
Employees | 1,693 |
Sector | Health Care |
Industries |
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Past 5 years
USD 14.93
USD 32.39
USD 9.56
USD 20.35
USD 21.63
StockViz Staff
January 15, 2025
Any question? Send us an email